01:12 , Jun 28, 2019 |  BC Extra  |  Company News

June 27 Company Quick Takes: Zogenix soars; plus Gardasil, Darzalex, Soliris and more

Zogenix shares surge after agreement to resubmit Fintepla NDA  Zogenix Inc. (NASDAQ:ZGNX) closed up $8.24 (21%) to $47.65 on Thursday after the company announced it had reached an agreement with FDA to resubmit its NDA...
07:00 , Oct 14, 2013 |  BC Week In Review  |  Company News

Alliance for Lupus Research (ALR), Lupus Research Institute news

The alliance and institute partnered to analyze a database of 70 drugs approved for other indications that could be used to treat lupus. The analysis will be funded by a grant from the partners. A...
08:00 , Nov 19, 2012 |  BC Week In Review  |  Company News

Pfizer, Alliance for Lupus Research (ALR) deal

The Alliance partnered with Pfizer to discover therapies to treat lupus under the pharma's Global Centers for Therapeutic Innovation initiative. The partners will co-fund translational research, which is slated to begin next half. The partners...
08:00 , Jan 17, 2005 |  BC Week In Review  |  Company News

Dynavax other research news

DVAX announced that the Alliance for Lupus Research (ALR) awarded a $500,000 grant to explore new treatment approaches for SLE based on DVAX's novel immunoregulatory sequences (IRS) technology. IRS inhibits the toll-like receptor (TLR)-induced inflammatory...